Lack of XAGE-1b and NY-ESO-1 in metastatic lymph nodes may predict the potential survival of stage III melanoma patients.
about
Lack of XAGE-1b and NY-ESO-1 in metastatic lymph nodes may predict the potential survival of stage III melanoma patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Lack of XAGE-1b and NY-ESO-1 i ...... f stage III melanoma patients.
@en
Lack of XAGE-1b and NY-ESO-1 i ...... f stage III melanoma patients.
@nl
type
label
Lack of XAGE-1b and NY-ESO-1 i ...... f stage III melanoma patients.
@en
Lack of XAGE-1b and NY-ESO-1 i ...... f stage III melanoma patients.
@nl
prefLabel
Lack of XAGE-1b and NY-ESO-1 i ...... f stage III melanoma patients.
@en
Lack of XAGE-1b and NY-ESO-1 i ...... f stage III melanoma patients.
@nl
P2093
P2860
P356
P1476
Lack of XAGE-1b and NY-ESO-1 i ...... f stage III melanoma patients.
@en
P2093
Eiichi Nakayama
Eiichi Sato
Kaori Kameyama
Keiji Tanese
Mariko Mori
Yutaka Kawakami
P2860
P304
P356
10.1111/1346-8138.13730
P577
2017-01-20T00:00:00Z